Fundz

Rqm+™ Acquires Germany Based Cro Kottmann

PRIVATEAug 28, 2023

Acquiring Company

RQM+

Acquired Company

Kottmann

GermanyBiotechnologyHealth CareMedicalConsultingBiotechnologyHealth CareMedical

Description

RQM+, a global leader in MedTech services, announces its acquisition of CRO Kottmann, a premier contract research organization (CRO) renowned for its excellent customer service, scientific clinical research and quality in the key market of Germany. This significant move further supports RQM+’s dedication to strategic growth and presence in Europe and emphasizes its dominance in the growing areas of MedTech.

Quick answer

RQM+ is acquiring Kottmann, announced August 28, 2023.

How much did RQM+ pay for Kottmann?
The deal value was not disclosed.
What does RQM+ do?
RQM+ is the world's leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle.
Where are RQM+ and Kottmann based?
Kottmann is based in Germany.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Consulting

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at RQM+, and when

When RQM+ changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day RQM+ raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RQM+, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RQM+. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RQM+

About

RQM+ is the world's leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle. RQM+’s global team of clinical, technical, and top industry experts push the boundaries of excellence. With more former FDA, Medicines, and Healthcare Products Regulatory Agency (MHRA) and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. We reduce commercialization risk by offering a full complement of CRO services to progress medical devices, digital therapeutics and diagnostics onto the market and keep them there. In addition to early- and mid-stage MedTech companies, we currently work with 19 of the top 20 medical device manufacturers and seven of the top 10 IVD companies. For more information, visit RQMplus.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RQM+ makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for RQM+'s next move

Learn about Strategic plan

Frequently asked

Who acquired Kottmann?

Kottmann was acquired by RQM+. The deal was reported on August 28, 2023. RQM+ is the world's leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle. RQM+ is privately held and operates in Biotechnology.

When did RQM+ acquire Kottmann?

RQM+'s acquisition of Kottmann was reported on August 28, 2023. RQM+, a global leader in MedTech services, announces its acquisition of CRO Kottmann, a premier contract research organization (CRO) renowned for its excellent customer service, scientific clinical research and quality in the key market of Germany. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Kottmann do?

CRO Dr. med. Kottmann, based in Germany, is a leading Contract Research Organization (CRO) celebrated for its unmatched customer service and commitment to quality. It is privately held, operating in Biotechnology, and is based in Germany.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.